Cystic fibrosis (pseudomonas lung infection) - colistimethate sodium and tobramycin: Expert comments on the ACD
Cystic fibrosis (pseudomonas lung infection) - colistimethate sodium and tobramycin: Professor Andrew Greening (clinical specialist) nominated by Healthcare Improvement Scotland
Cystic fibrosis (pseudomonas lung infection) - colistimethate sodium and tobramycin: Dr Robert Ian Ketchell (clinical specialist) nominated by Forest Laboratories UK
Cystic fibrosis (pseudomonas lung infection) - colistimethate sodium and tobramycin: Emma Lake and Nikki Samsa (patient experts) nominated by the Cystic Fibrosis Trust - joint submission
This page was last updated: 25 January 2013